March 22, 2018 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix International N.V., (NASDAQ:OFIX), a global medical device company focused on musculoskeletal healing products and value added services, announced the U.S. Food and Drug Administration (FDA) 510(k)clearance for its new internal fixation system, the G-Beam™ Fusion Beaming System. Designed primarily for the treatment of Charcot foot, a debilitating condition where […]